These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6761080)

  • 41. Penetration of eight beta-lactam antibiotics into the peritoneal fluid. A pharmacokinetic investigation.
    Wittman DH; Schassan HH
    Arch Surg; 1983 Feb; 118(2):205-13. PubMed ID: 6849637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pleiotropic properties of a beta-lactam antibiotic-hypersensitive mutant derived from Proteus vulgaris IFO 3167.
    Hamakado T; Yoshida T; Kido Y; Miyagawa E; Motoki Y
    Microbiol Immunol; 1985; 29(1):81-4. PubMed ID: 3887108
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of antibacterial therapy on renal lysozyme levels in rats developing bacterial pyelonephritis.
    Eudy WW; Burrous SE
    Antimicrob Agents Chemother; 1972 Feb; 1(2):85-9. PubMed ID: 4618454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two compartment kinetic model with multiple artificial capillary units.
    Blaser J; Stone BB; Zinner SH
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():131-7. PubMed ID: 3980324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of antibiotics in the elderly.
    Ljungberg B; Nilsson-Ehle I; Nordbring F
    Eur J Clin Microbiol; 1987 Jun; 6(3):329-30. PubMed ID: 3622505
    [No Abstract]   [Full Text] [Related]  

  • 46. Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgaris.
    Dalhoff A; Gehl AE; Lode H
    Chemotherapy; 1982; 28(5):381-9. PubMed ID: 6754281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of mezlocillin and cefoxitin against Proteus morganii in the granuloma pouch model.
    Dalhoff A
    Eur J Clin Microbiol; 1982 Aug; 1(4):243-7. PubMed ID: 6217067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mode of interaction between immunoglobulin G and mezlocillin against beta-lactamase producing bacteria.
    Dalhoff A; Brunner H
    Arzneimittelforschung; 1983; 33(12):1666-71. PubMed ID: 6607736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.
    Araki H; Minami S; Watanabe Y; Yasuda T
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1131-6. PubMed ID: 1929254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C; Legakis NJ; Papafragas E; Marinis E
    Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
    Dalhoff A; Gehl AE; Gau W; Lode H
    Chemotherapy; 1982; 28(6):444-53. PubMed ID: 6761080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical and laboratory significance of inducible beta-lactamases].
    Bedenić B; Zagar Z
    Lijec Vjesn; 1995; 117(9-10):249-53. PubMed ID: 8643019
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.